SUPN Supernus Pharmaceuticals Inc

NASDAQ
$28.61

Supernus Pharmaceuticals Inc (SUPN) Earnings News

Earnings press releases, previews and reviews for Supernus Pharmaceuticals Inc (SUPN), newest first. Our most recent is review: Supernus Ends Its Standalone Era With a Big Beat and Higher Guidance, but the Indivior Merger Now Drives the Story.